Testing effectiveness (Phase 2)UnknownNCT03242603
What this trial is testing
Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells
Who this might be right for
Neuroblastoma Recurrent
National University Hospital, Singapore 5